Skip to main content
. 2010 Feb 16;102(5):922–929. doi: 10.1038/sj.bjc.6605569

Figure 1.

Figure 1

Examples of tissue arrays (TAs) with immunostaining for each protein evaluated in prostate carcinoma. (A) Matrix metalloproteinase (MMP)-1, (B) MMP-2, (C) MMP-7, (D) MMP-9, (E) MMP-11, (F) MMP-13, (G) MMP-14, (H) tissue inhibitors of metalloprotease (TIMP)-1, (I) TIMP-2, (J) TIMP-3, (K) normal tissue and (L) tumour with IgG.